Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Purissimus is a long-standing Argentine pharmaceutical company founded in 1912, specializing in the development, manufacturing, and commercialization of high-quality medicinal products. The company maintains a diverse portfolio covering therapeutic areas such as gastroenterology, cardiology, respiratory health, and neurology. Purissimus is recognized for its commitment to innovation and quality standards, operating modern manufacturing facilities that comply with international GMP regulations. Its business model includes both proprietary product development and strategic partnerships for the distribution of specialized therapies in the Latin American market. The company is particularly well-regarded for its gastrointestinal line, including the widely recognized brand Lanzopral. Purissimus continues to expand its reach through licensing agreements with global pharmaceutical leaders to bring advanced treatments to the regional market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purissimus.